Our Team: LUKE WANDER
Research Study Coordinator
1660 S. Columbian Way, MS-127, Seattle, WA 98108, lwander@u.washington.edu

Education
Sept. 2004-present: University of Washington, Seattle, WA
M.D. candidate

Sept. 1999-May 2003: University of Washington, Seattle, WA
Post-baccalaureate, GPA 3.92

Jan. 1993-March 1997: Savannah College of Art & Design,
Savannah, GA
B.F.A. in graphic design and computer animation, G.P.A. 3.89


Professional Experience
Sept. 2003-present: University of Washington Parkinson's Genetic Research Group, Seattle, WA
Research study coordinator

June 2005-Feb. 2006: University of Washington Medical Student Research Training Program, Seattle, WA
Student researcher

June 2002-Sept. 2003: University of Washington Diabetes Research Group, Seattle, WA
Research study assistant


Honors
Alpha Omega Alpha, elected in junior year, vice president of University of Washington chapter
UW George F. Odland Scholar, 2006-2007
UW School of Medicine Endowed Scholarship, 2004-2006

Papers/Abstracts
Chun LS, Samii A, Hutter CM, Griffith A, Roberts JW, Leis BC, Mosley AD, Wander PL, Edwards KL, Payami H, Zabetian CP. DBH-1021C->T does not modify risk or age at onset in Parkinson's disease. Ann Neurol. 2007 Jul;62(1):99-101.

Wander PL, Raskind MA, Zabetian CP, Warren DJ, Kumata J, Peskind ER. Prazosin improves nightmares and sleep disturbance and does not worsen daytime symptoms in posttraumatic stress disorder. J Investig Med. 2006 Jan;54(1):S167.